575 related articles for article (PubMed ID: 16841648)
1. Revival of the fittest. PHOs have dropped in number, but many are still going strong despite antitrust scrutiny--and there's even renewed interest.
Taylor M
Mod Healthc; 2006 Jun; 36(26):24-6. PubMed ID: 16841648
[No Abstract] [Full Text] [Related]
2. Limits placed on PHOs by antitrust rulings, transitional structure for integration.
Health Care Strateg Manage; 1995 Nov; 13(11):14-5. PubMed ID: 10151858
[No Abstract] [Full Text] [Related]
3. Special report: Antitrust and health care. Anticipating antitrust pitfalls in new health care ventures.
Brett BJ; Porter KD; Rinehart SG
Benders Health Care Law Mon; 1996 Feb; ():3-12. PubMed ID: 10158210
[No Abstract] [Full Text] [Related]
4. Integration options.
Williams L
J Health Hosp Law; 1996; 29(2):88-96, 106. PubMed ID: 10160177
[No Abstract] [Full Text] [Related]
5. Health care joint ventures and the antitrust laws: a guardedly optimistic prognosis.
Gotts IK
J Contemp Health Law Policy; 1994; 10():169-93. PubMed ID: 10134809
[No Abstract] [Full Text] [Related]
6. Not so fast. Doctors and hospitals are running head-on into federal antitrust laws.
Serafini MW
Natl J (Wash); 1994 Dec; 26(51-52):2967-70. PubMed ID: 10139127
[No Abstract] [Full Text] [Related]
7. How are you going to pay for it?
Barkley R
Integr Healthc Rep; 1994 Nov; ():1-8. PubMed ID: 10154234
[No Abstract] [Full Text] [Related]
8. PHOs fall short of expectations. Despite failings, networks may have role as a transition to vertical integration.
Jaklevic MC
Mod Healthc; 1995 Oct; 25(41):77-8, 80, 82. PubMed ID: 10152068
[TBL] [Abstract][Full Text] [Related]
9. Legally speaking: Federal Trade Commission issues positive advisory opinions on antitrust implications of clinical integration.
Wright R
J Ark Med Soc; 2009 Oct; 106(4):88-9. PubMed ID: 19813398
[TBL] [Abstract][Full Text] [Related]
10. Strategic health system development and managed care delivery.
Nauert RC
J Health Care Finance; 2002; 29(2):5-17. PubMed ID: 12462655
[TBL] [Abstract][Full Text] [Related]
11. Antitrust developments in healthcare: emphasis on net effects rather than structural presumptions.
Ewing KP; Koslov TI
Benders Health Care Law Mon; 1996 Mar; ():3-12. PubMed ID: 10158209
[No Abstract] [Full Text] [Related]
12. Insights for hospitals: the 1994 health care antitrust enforcement policy statements.
Marx D; Busey RC
J Health Hosp Law; 1995; 28(3):143-50. PubMed ID: 10155907
[No Abstract] [Full Text] [Related]
13. Hope for antitrust relief.
Besaw L
Tex Med; 1996 Jun; 92(6):26-9. PubMed ID: 8685841
[No Abstract] [Full Text] [Related]
14. Government agencies soften stance on what constitutes price fixing.
Ettinger DA; Lasser ML
Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
[TBL] [Abstract][Full Text] [Related]
15. Converting new antitrust guidance into action.
Johnson BA
Med Group Manage J; 1997; 44(1):22-6, 62. PubMed ID: 10164264
[TBL] [Abstract][Full Text] [Related]
16. Antitrust exemption: are health providers crying wolf?
Barnett AA
J Am Health Policy; 1993; 3(3):38-41. PubMed ID: 10125734
[TBL] [Abstract][Full Text] [Related]
17. The legal framework for effective competition.
Berenson RA; Hastings DA; Kopit WG
Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
[TBL] [Abstract][Full Text] [Related]
18. Networks can avoid antitrust scrutiny.
Waxman JM
Provider; 1997 Feb; 23(2):42-5. PubMed ID: 10167120
[No Abstract] [Full Text] [Related]
19. The future of provider-sponsored HMOs.
Votz D; Cochrane JD
Integr Healthc Rep; 1996 Aug; ():1-9. PubMed ID: 10161506
[No Abstract] [Full Text] [Related]
20. Examining social and organizational factors of physician integration.
Greene BR
Front Health Serv Manage; 1998; 14(3):37-40; discussion 49-50. PubMed ID: 10177382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
